BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 37108244)

  • 1. Energy Metabolism Is Altered in Radioresistant Rectal Cancer.
    Buckley CE; Yin X; Meltzer S; Ree AH; Redalen KR; Brennan L; O'Sullivan J; Lynam-Lennon N
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CoA Synthase (
    Ferrandon S; DeVecchio J; Duraes L; Chouhan H; Karagkounis G; Davenport J; Orloff M; Liska D; Kalady MF
    Cancer Res; 2020 Jan; 80(2):334-346. PubMed ID: 31704889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of Poor Response to Neoadjuvant Chemoradiation in Patients With Rectal Cancer Using a DNA Repair Deregulation Score: Picking the Losers Instead of the Winners.
    Jimenez L; Perez RO; São Julião GP; Vailati BB; Fernandez LM; Gama-Rodrigues J; Habr-Gama A; DeVecchio J; Kalady MF; Camargo AA
    Dis Colon Rectum; 2020 Mar; 63(3):300-309. PubMed ID: 31842156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive Significance of Mucinous Histology on Pathologic Complete Response Rate Following Capecitabine-Based Neoadjuvant Chemoradiation in Rectal Cancer: a Comparative Study.
    Hosseini S; Nguyen N; Mohammadianpanah M; Mirzaei S; Bananzadeh AM
    J Gastrointest Cancer; 2019 Dec; 50(4):716-722. PubMed ID: 29984382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin is a metabolic modulator and radiosensitiser in rectal cancer.
    Buckley CE; O'Brien RM; Nugent TS; Donlon NE; O'Connell F; Reynolds JV; Hafeez A; O'Ríordáin DS; Hannon RA; Neary P; Kalbassi R; Mehigan BJ; McCormick PH; Dunne C; Kelly ME; Larkin JO; O'Sullivan J; Lynam-Lennon N
    Front Oncol; 2023; 13():1216911. PubMed ID: 37601689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered mitochondrial function and energy metabolism is associated with a radioresistant phenotype in oesophageal adenocarcinoma.
    Lynam-Lennon N; Maher SG; Maguire A; Phelan J; Muldoon C; Reynolds JV; O'Sullivan J
    PLoS One; 2014; 9(6):e100738. PubMed ID: 24968221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene expression profile is associated with chemoradiation resistance in rectal cancer.
    Gantt GA; Chen Y; Dejulius K; Mace AG; Barnholtz-Sloan J; Kalady MF
    Colorectal Dis; 2014 Jan; 16(1):57-66. PubMed ID: 24034224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA expression profile associated with response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients.
    Svoboda M; Sana J; Fabian P; Kocakova I; Gombosova J; Nekvindova J; Radova L; Vyzula R; Slaby O
    Radiat Oncol; 2012 Nov; 7():195. PubMed ID: 23167930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Semiquantitative Volumetry by Sequential PET/CT May Improve Prediction of Complete Response to Neoadjuvant Chemoradiation in Patients With Distal Rectal Cancer.
    Dos Anjos DA; Perez RO; Habr-Gama A; São Julião GP; Vailati BB; Fernandez LM; de Sousa JB; Buchpiguel CA
    Dis Colon Rectum; 2016 Sep; 59(9):805-12. PubMed ID: 27505108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ku70, Ku80, and sClusterin: A Cluster of Predicting Factors for Response to Neoadjuvant Chemoradiation Therapy in Patients With Locally Advanced Rectal Cancer.
    Pucci S; Polidoro C; Joubert A; Mastrangeli F; Tolu B; Benassi M; Fiaschetti V; Greco L; Miceli R; Floris R; Novelli G; Orlandi A; Santoni R
    Int J Radiat Oncol Biol Phys; 2017 Feb; 97(2):381-388. PubMed ID: 28068245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miRNA expressions in rectal cancer as predictors of response to neoadjuvant chemoradiation therapy.
    Kheirelseid EA; Miller N; Chang KH; Curran C; Hennessey E; Sheehan M; Newell J; Lemetre C; Balls G; Kerin MJ
    Int J Colorectal Dis; 2013 Feb; 28(2):247-60. PubMed ID: 22903298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomic signatures of radioresistance: Alteration of inflammation, angiogenesis and metabolism-related factors in radioresistant oesophageal adenocarcinoma.
    Marcone S; Buckley A; Ryan CJ; McCabe M; Lynam-Lennon N; Matallanas D; O Sullivan J; Kennedy S
    Cancer Treat Res Commun; 2021; 27():100376. PubMed ID: 33882379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNA-seq profiling of a radiation resistant and radiation sensitive prostate cancer cell line highlights opposing regulation of DNA repair and targets for radiosensitization.
    Young A; Berry R; Holloway AF; Blackburn NB; Dickinson JL; Skala M; Phillips JL; Brettingham-Moore KH
    BMC Cancer; 2014 Nov; 14():808. PubMed ID: 25369795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding and Resetting Radiation Sensitivity in Rectal Cancer.
    Kelley KA; Ruhl RA; Rana SR; Dewey E; Espinosa C; Thomas CR; Martindale RG; Anand S; Tsikitis VL
    Ann Surg; 2017 Oct; 266(4):610-616. PubMed ID: 28742699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of different response to ionizing irradiation in isogenic head and neck cancer cell lines.
    Todorovic V; Prevc A; Zakelj MN; Savarin M; Brozic A; Groselj B; Strojan P; Cemazar M; Sersa G
    Radiat Oncol; 2019 Nov; 14(1):214. PubMed ID: 31775835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular changes consistent with increased proliferation and invasion are common in rectal cancer.
    Hughes R; Parry J; Beynon J; Jenkins G
    Clin Transl Oncol; 2011 Oct; 13(10):753-9. PubMed ID: 21975339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The molecular basis of chemoradiosensitivity in rectal cancer: implications for personalized therapies.
    Grade M; Wolff HA; Gaedcke J; Ghadimi BM
    Langenbecks Arch Surg; 2012 Apr; 397(4):543-55. PubMed ID: 22382702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging roles of non‑coding RNAs in the response of rectal cancer to radiotherapy (Review).
    Ha Thi HT; Duong HQ; Hong S
    Int J Oncol; 2021 Mar; 58(3):344-358. PubMed ID: 33650664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. XRCC2 as a predictive biomarker for radioresistance in locally advanced rectal cancer patients undergoing preoperative radiotherapy.
    Qin CJ; Song XM; Chen ZH; Ren XQ; Xu KW; Jing H; He YL
    Oncotarget; 2015 Oct; 6(31):32193-204. PubMed ID: 26320178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Identification of gene biomarkers to predict responses to neoadjuvant chemoradiotherapy in patients with rectal cancer and pathways enrichment analysis].
    Wang XJ; Yu Q; Chi P; Lin HM; Lu XR; Huang Y; Xu ZB; Huang SH; Sun YW; Ye DX
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Dec; 22(12):1183-1187. PubMed ID: 31874536
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.